Main Article Content
Aims: The aim of this study was to observe the effect of Apple Cider Vinegar (ACV) in combination with Metformin on the Body Mass Index (BMI) and glycemic control of newly diagnosed type 2 diabetic patients.
Study Design: Single arm pre post quasi experimental clinical trial.
Place and Duration of Study: Department of Medicine of a tertiary care hospital and a Diabetes and Endocrinology clinic, based in Karachi, Pakistan from April to July 2019.
Methodology: A total of 30 newly diagnosed type 2 diabetic patients were enrolled in the study (Males: 17; females: 13; age range: 27-55 years) after obtaining written informed consent. The parameters of Body weight, BMI, Fasting Blood Sugar (FBS) and Hemoglobin A1c (HbA1c) of each patient were assessed before and after 12 weeks of treatment with Metformin 750 mg plus 2 tablespoons of ACV per day. The baseline and post treatment values of the aforementioned were compared with each other.
Results: In all the 30 patients assessed after 12 weeks of treatment, the weight was significantly reduced from 85.66±18.30 kg. to 82.96±18.43 kg with a consequently significant change in the BMI from 29.38±5.08 kg/m2 to 28.43±5.16 kg/m2. Moreover, the glycemic control, assessed as FBS and HbA1c also showed significant reduction in the FBS (127.76±9.17 to 121.23±9.54) and HbA1c (7.14±0.29 to 6.92±0.29) after 12 weeks of treatment in all 30 patients (p<0.01).
Conclusion: Apple Cider Vinegar seems to be effective therapy in combination with metformin for newly diagnosed type 2 diabetic patients in improving glycemic control as well as augmenting weight reduction.
Anonymous. WHO, W. The top 10 causes of death; 2014.
(Accessed 15th December 2019)
Ozougwu JC, Obimba KC, Belonwu CD, Unakalamba CB. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. Journal of Physiology and Pathophysiology. 2013;4(4):46-57.
Kohei KAKU. Pathophysiology of type 2 diabetes and its treatment policy. JMAJ. 2010;53(1):41-46.
Nuttall FQ. Body mass index: obesity, BMI, and health: A critical review. Nutrition. 2015;50(3):117.
Samson SL, Garber AJ. Metformin and other biguanides: Pharmacology and therapeutic usage. International Textbook of Diabetes Mellitus. 2015;641-656.
Praharaj SK, Jana AK, Goyal N, Sinha VK. Metformin for olanzapine‐induced weight gain: A systematic review and meta‐ analysis. British Journal of Clinical Pharmacology. 2011;71(3):377-382.
Silvia S, Franco G, Fabio V, De GP, Iacoviello M, Licchelli B, Guastamacchia E, Giagulli V, Triggiani V. Metformin: Up to Date. Endocrine, Metabolic & Immune Disorders Drug Targets; 2019.
Johnston CS, Gaas CA. Vinegar: Medicinal uses and antiglycemic effect. Medscape General Medicine. 2006;8(2):61.
Johnston CS, Buller AJ. Vinegar and peanut products as complementary foods to reduce postprandial glycemia. Journal of the American Dietetic Association. 2005; 105(12):1939-1942.
Johnston CS, White AM, Kent SM. Preliminary evidence that regular vinegar ingestion favorably influences hemoglobin A1c values in individuals with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 2009;84(2):e15- e17.
Kondo T, Kishi M, Fushimi T, Ugajin S, Kaga T. Vinegar intake reduces body weight, body fat mass and serum triglyceride levels in obese Japanese subjects. Bioscience, Biotechnology and Biochemistry. 2009;73(8):1837-1843.
Pusparatha SB, Devi RG, Jyothipriya A. Effects of apple cider vinegar on diabetic and obese patients. Drug Invention. 2019; 12(5).
Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2011; 8:228–36.
Violi F, Targher G, Vestri A, et al. Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and study design. Am Heart J. 2017;189:120–7.
Gardner CD, Trepanowski JF, Del Gobbo LC, et al. Effect of low-fat vs low-carbohydrate diet on 12-month weight loss in overweight adults and the association with genotype pattern or insulin secretion: The DIETFITS randomized clinical trial. JAMA. 2018;319:667–79.
Naqvi IH, Talib A, Akhter ST, Abdi SR, Rizvi SNZ, Ubaid M. Peripheral neuropathy and vasculopathy; Frequency and associated risk factors in newly diagnosed treatment naive type 2 diabetes. Open Journal of Endocrine and Metabolic Diseases. 2008;8(05):125.
Apolzan JW, Venditti EM, Edelstein SL, Knowler WC, Dabelea D, Boyko EJ, Pi-Sunyer X, Kalyani RR, Franks PW, Srikanthan P, Gadde KM. Long-term weight loss with metformin or lifestyle intervention in the diabetes prevention program outcomes study. Annals of Internal Medicine. 2019;170(10):682-690.
Griffin C, McGowan E, Griffin M. May. weight loss in PCOS-benefits of metformin and liraglutide-a single institution experience. In 21st European Congress of Endocrinology Bio Scientifica. 2019;63.
Basharat S, Gilani SA, Qamar MM, Basharat A. Therapeutic effect of apple cider vinegar on diabetes mellitus. Rawal Medical Journal. 2019;44(4):884-887.
Sanchez-Rangel E, Inzucchi SE. Metformin: Clinical use in type 2 diabetes. Diabetologia. 2017;60(9):1586-1593.
Xia C, Liang S, He Z, Zhu X, Chen R, Chen J. Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells. European Journal of Pharmaco-logy. 2018;830:59-67.
Pratley RE, Eldor R, Raji A, Golm G, Huyck SB, Qiu Y, Sunga S, Johnson J, Terra SG, Mancuso JP, Engel SS. Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The vertis factorial randomized trial. Diabetes, Obesity and Metabolism. 2018;20(5): 1111-1120.
Yanto TA, Huang I, Kosasih FN, Lugito NPH. Nightmare and abnormal dreams: Rare side effects of metformin? Case Reports in Endocrinology; 2018.
Perry M. Metformin use and B12 deficiency. Journal of Prescribing Practice. 2019;1(Sup3):S10-S13.
Halima BH, Sarra K, Houda BJ, Sonia G, Abdallah A. Antidiabetic and antioxidant effects of apple cider vinegar on normal and streptozotocin-induced diabetic rats. International Journal for Vitamin and Nutrition Research; 2019.
Mohammad Pourhodki R, Sargolzaei MS. The effects of apple vinegar on fasting blood sugar (FBS) and glycosylated hemoglobin in patients with type 2 diabetes. Prensa Medica Argentina. 2019;104:1-4.
Kausar S, Abbas MA, Hajra Ahmad NY, Ahmed Z, Humayun N, Ashfaq H, Humayun A. Effect of apple cider vinegar in type 2 diabetic patients with poor glycemic control: A randomized placebo controlled design®. Health Sciences. 2019; 8(2):149-159.
Morgan Joanna, Sapha Mosawy. The potential of apple cider vinegar in the management of type 2 diabetes. International Journal of Diabetes Research. 2016;5(6):129-34.
Kausar S, Humayun A, Ahmed Z, Abbas MA, Tahir A. Effect of apple cider vinegar on glycemic control, hyperlipidemia and control on body weight in type 2 diabetes patients. Health Sciences. 2019;8(5): 59-74.
Cheng LJ, Jiang Y, Wu XV, Wang W. A Systematic review and meta‐analysis: vinegar consumption on glycemic control in adults with type 2 diabetes mellitus. Journal of Advanced Nursing; 2019.
Gheflati A, Bashiri R, Ghadiri-Anari A, Reza JZ, Kord MT, Nadjarzadeh A. The effect of apple vinegar consumption on glycemic indices, blood pressure, oxidative stress, and homocysteine in patients with type 2 diabetes and dyslipidemia: A randomized controlled clinical trial. Clinical Nutrition ESPEN. 2019;33:132-138.
Santos HO, De Moraes WM, Da Silva GA, Prestes J, Schoenfeld BJ. Vinegar (acetic acid) intake on glucose metabolism: A narrative review. Clinical Nutrition ESPEN; 2019.